USPTO serial 87107393
Serial No. 87107393
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 2, 2017
- Examiner
- EDWARDS, ALICIA COLLINS
- Law office
- TMO LAW OFFICE 115
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 87107393?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Le Mont-sur-Lausanne, CH
Le Mont-sur-Lausanne, CH
Le Mont-sur-Lausanne, CH
Jersey City, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay Kaplan
Lindsay Kaplan L. Kaplan LawPO Box 4062Kingston, NY 12402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; [ sanitary preparations for medical purposes; adjuvants for medical purposes; ] biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; [ pharmaceutical skin lotions; ] tissues impregnated with pharmaceutical lotions; medical dressings; [ surgical cloth tissues; medicated skin care preparations; ] pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; [ products and preparations for medical purposes for cleaning the skin; ] solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; [ all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; ] plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary use | ACTIVE | May 15, 2010 |
| 010 | Medical devices, namely, medical tubes, vials, [ jars, ] bags, [ pouches, ] cartridges, [ bottles, ] cylinders or pods, syringes, needles, holders, gels, connectors, tourniquets, [ plaster, pads, ] masks, [ pliers, ] creams, spatulas, flasks, [ discs, dispensers, nozzles, ] stoppers, adapters, cannulas, transfer devices, ampoules, [ backstops, ] anticoagulants, coagulation activators, [ hyaluronic acid and chitosan, ] sold as a unit, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, [ chitosan ] or any combinations thereof; kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely, medical tubes, vials, [ jars, bags, pouches, cartridges, bottles, cylinders or pods, ] syringes and needles for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments, namely, tubes, containers, syringes, needles, for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology, mesotherapy, cardiovascular, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; centrifuges for medical purposes; [ suture material; cases fitted for medical instruments; ] receptacles for applying medicines, namely, medical containers, [ cannula, ] syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; containers specially adapted for storing tissue and biological samples for medical purposes; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; medical apparatus used for taking blood; medical apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels | ACTIVE | May 15, 2010 |
| 041 | Educational services, namely, designing, organizing, and providing classes, training, educational colloquiums, symposiums, conferences, seminars, congresses, workshops, and discussion fora in real time over Internet-type networks or Intranet-type networks; training for business executives, health care workers, health care specialists, medical doctors and patients and providing consultation and advice in connection therewith; providing non-downloadable electronic publications, namely, books, magazines, and brochures containing advice and information for educational purposes, training purposes or instructional purposes provided online from a computer database or the Internet; [ entertainment services, namely, organizing, arranging, and providing entertainment events in the nature of sporting competitions, live music concerts, radio programs, television programs, and theatre productions; ] publication of [ newspapers, magazines, ]journals [, and electronic books] ; vocational guidance and educational and training advice; all of the above services rendered in the field of healthcare, surgery, veterinary applications, cosmetics, beauty care, marketing, business management, consultation, cellular and tissue enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine, as well as isolating, treating and injecting blood platelets or cells into patients | ACTIVE | May 15, 2010 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Regen Lab SA
- Other trademarks owned by Regen Lab SA
- Other trademarks owned by Regen Lab SA
- Other trademarks owned by REGENLAB USA LLC
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 2, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 5, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Sep 5, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 6, 2023 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 6, 2023 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 31, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 2, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 10, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jan 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 2, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 13, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 13, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 13, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 13, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 13, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 21, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 1, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 1, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 5, 2017 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 2, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 14, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 14, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 25, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 22, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 22, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2016 | NWAP | NEW APPLICATION ENTERED | — |